These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32339484)

  • 21. Ultrasound localisation and removal of non-palpable Implanon implants.
    James P; Trenery J
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):225-8. PubMed ID: 16704477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuing need for and provision of a service for non-standard implant removal.
    Pillai M; Gazet AC; Griffiths M
    J Fam Plann Reprod Health Care; 2014 Apr; 40(2):126-32. PubMed ID: 24081828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Pop-out" method of levonorgestrel implant removal.
    Pymar HC; Creinin MD; Schwartz JL
    Contraception; 1999 Jun; 59(6):383-7. PubMed ID: 10518233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Location and removal of non-palpable Implanon implants with the aid of ultrasound guidance.
    Singh M; Mansour D; Richardson D
    J Fam Plann Reprod Health Care; 2006 Jul; 32(3):153-6. PubMed ID: 16857066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arm flexion during ultrasound assists localization of an intramuscular etonogestrel contraceptive implant.
    Biskamp C; Kauffman RP
    Contraception; 2016 Mar; 93(3):273-5. PubMed ID: 26549857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mobilizing stakeholders for implant removals in Burkina Faso using landscape assessment data.
    Tiendrebeogo J; Arnold B; Ouedraogo Y; Haws R; Garane LP; Ouedraogo V; Gouem M; Coulibaly A; Bougma M
    BMC Womens Health; 2024 May; 24(1):301. PubMed ID: 38769558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perspectives on contraceptive implant use in women living with HIV in Cape Town, South Africa: a qualitative study among primary healthcare providers and stakeholders.
    Brown A; Harries J; Cooper D; Morroni C
    BMC Public Health; 2019 Jul; 19(1):1003. PubMed ID: 31349786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.
    Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B
    Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of etonogestrel implant beyond approved duration: prolonged contraceptive effectiveness.
    Ribeiro BC; Nogueira-Silva C; Afonso H; Silva PO; Reis ID
    Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):309-310. PubMed ID: 30203680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon.
    Wenzl R; van Beek A; Schnabel P; Huber J
    Contraception; 1998 Nov; 58(5):283-8. PubMed ID: 9883383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etonogestrel contraceptive implant: ulnar nerve damage.
    Prescrire Int; 2008 Apr; 17(94):63. PubMed ID: 18516815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database.
    Kang S; Niak A; Gada N; Brinker A; Jones SC
    Contraception; 2017 Dec; 96(6):439-445. PubMed ID: 28867440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA).
    Reed S; Do Minh T; Lange JA; Koro C; Fox M; Heinemann K
    Contraception; 2019 Jul; 100(1):31-36. PubMed ID: 30980829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etonogestrel implants - case studies of median nerve injury following removal.
    Gillies R; Scougall P; Nicklin S
    Aust Fam Physician; 2011 Oct; 40(10):799-800. PubMed ID: 22003483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.
    Deokar AM; Jackson W; Omar HA
    Int J Adolesc Med Health; 2011; 23(1):75-7. PubMed ID: 21721368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the "no compression" sonographic technique in identification and removal of an etonogestrel contraceptive implant: A case report.
    Sium AF; Wolderufael M; Grentzer JM
    Int J Gynaecol Obstet; 2022 Nov; 159(2):600-601. PubMed ID: 35762279
    [No Abstract]   [Full Text] [Related]  

  • 38. Etonogestrel implant (Implanon) for contraception.
    Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergic and infectious complications of Etonogestrel implant placements: A case series.
    Osterbur Badhey ML; Li S; Alimena S; Johnson NR; Bartz D
    Contraception; 2023 Jun; 122():109994. PubMed ID: 36871621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contraceptive implants--aberrations from insertion and removal procedures].
    Jørgensen NP
    Tidsskr Nor Laegeforen; 2010 Apr; 130(7):733-4. PubMed ID: 20379334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.